​Paediatric and Adolescent Haematology and Oncology

We treat our blood and cancer patients according to international treatment plants, and our treatment results of stem cell transplantations are in the international elite (Lancet Oncol. 2014;15(1):35-47):

Acute lymphoblastic leukaemia (ALL) is one of the most common paediatric cancer diseases. We adhere to the Nordic treatment plan, and we are even above the Nordic standard in the treatment results:

In between 1992 and 2000, the children diagnosed in our hospital had a survival rate of 91% after two years and 84% after five years. Since 2000, the respective percentages are 94% (two year prognosis) and 90% (five year prognosis).

The two year survival rate prognosis for the rarer acute myeloid leukaemia (AML) has increased from the beginning of the 90's treatment plan's 50% by the programme established in 2004 to the levels of 90%.

Our treatment is of high quality and it is family-centred. We received the achiever of the year award of the hospital district in 2012 for our professional team work.

The parents can participate in their child's hospital treatment 24 hours a day.

Meet our doctors

​	​Päivi Lähteenmäki MD, docent, paediatrician, paediatric haematology, head of section, paediatric and adolescent haematology and oncology • Special qualifications in: Paediatric haematology and oncology, the treatment of haemophilia • Publication areas: Late effects of paediatric oncology treatment, risk classification of paediatric leukaemia, laboratory diagnostics of anaemia
​	​Marika Grönroos MD, paediatrician, paediatric haematologist and oncologist • Special qualifications in: Palliative treatment, treatment of kidney tumours • Publication areas: Paediatric haematology and oncology, late effects of oncological treatment
​	​

Heads of our nursing staff

​	​Maarit Lehtinen Ward manager tel. 02 313 2463
​	​Terhi Uusitalo Assistant ward manager tel. 02 313 3416